TEVA PHARMACEUTICAL INDUSTRIES LIMITED Inactive Instrument
Calendar Teva Pharmaceutical Industries Limited Other OTC
Equities
TEVJF
IL0006290147
Chart calendar Teva Pharmaceutical Industries Limited
45c677860f82360d.j793VrUb7WKiwtICMZ_hSW7O9CLnYy-OafwrbHd_uC0.7fBDO-xZ2VfMo4s2d_25ERq2rEGDEmbqBL94LQcWjVjc90Vj0WveMdGFsQ~e72680a254527b6077bbfd4dfdbd8895
Upcoming events on Teva Pharmaceutical Industries Limited
Past events on Teva Pharmaceutical Industries Limited
| 06/06/2024 14:00 | Annual General Meeting |
| 14/05/2024 16:40 | BofA Securities Health Care Conference |
| 08/05/2024 13:00 | Q1 2024 Earnings Call |
| 08/05/2024 12:00 | Q1 2024 Earnings Release |
| 02/04/2024 | Schizophrenia International Research Society Congress |
| 31/01/2024 13:00 | Q4 2023 Earnings Call |
| 31/01/2024 12:00 | Q4 2023 Earnings Release |
| 08/01/2024 16:15 | JPMorgan Healthcare Conference |
| 28/11/2023 13:20 | Evercore ISI HealthCONx Conference |
| 08/11/2023 13:00 | Q3 2023 Earnings Call |
| 08/11/2023 12:00 | Q3 2023 Earnings Release |
| 01/11/2023 | Huntington Study Group Meeting |
| 04/10/2023 13:00 | Sanofi Pharmaceutical Industry Company and Teva Pharmaceutical Industries Ltd Collaboration Agreemen |
| 11/09/2023 13:40 | Morgan Stanley Global Healthcare Conference |
| 09/09/2023 20:00 | Psych Congress |
| 07/09/2023 | Psych Congress - Poster #104 |
| 07/09/2023 | Psych Congress - Poster #130 |
| 07/09/2023 | Psych Congress - Poster #90 |
| 07/09/2023 | Psych Congress - Poster #134 |
| 07/09/2023 | Psych Congress - Poster #109 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 16 887 17 254 -2.13% | 16 659 16 599 0.36% | 15 878 16 125 -1.53% | 14 925 14 952 -0.18% | 15 846 15 349 3.24% | 16 002 |
|
EBITDA Million USD | Released Forecast Spread | 4 685 4 678 0.16% | 4 912 4 899 0.26% | 4 911 4 862 1.01% | 4 598 4 702 -2.22% | 4 818 4 520 6.58% | 4 769 |
|
EBIT Million USD | Released Forecast Spread | 4 142 4 108 0.82% | 4 388 4 333 1.27% | 4 401 4 355 1.05% | 4 139 4 163 -0.57% | 4 361 4 050 7.67% | 4 285 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1 265 1 262 -200.22% | -4 406 1 060 -515.66% | 658 1 625 -59.51% | 0,00 0,00 - | -624 -916 31.88% | -99,0 |
|
Net income Million USD | Released Forecast Spread | -999 -806 -23.87% | -3 990 -3 864 -3.27% | 417 954 -56.3% | -2 353 -494 -375.86% | -559 343 -262.9% | 816 |
|
EPS USD | Released Forecast Spread | -0,91 -0,73 -23.86% | -3,64 -3,48 -4.56% | 0,38 0,76 -50.04% | -2,12 -0,45 -370.01% | -0,50 -0,24 -107.75% | 0,96 |
| Announcement Date | 12/02/20 | 10/02/21 | 09/02/22 | 08/02/23 | 31/01/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 661 3 754 -2.48% | 3 786 3 775 0.29% | 3 595 3 854 -6.72% | 3 884 3 905 -0.54% | 3 661 3 589 2% | 3 878 3 720 4.24% | 3 850 3 736 3.05% | 4 457 4 010 11.15% | 3 819 3 740 2.12% | 4 021 | 4 045 | 4 143 | 3 845 | 3 976 |
|
EBITDA Million USD | Released Forecast Spread | 1 135 1 096 3.54% | 1 134 1 138 -0.39% | 1 089 1 181 -7.77% | 1 240 1 332 -6.93% | 899 1 119 -19.69% | 1 125 1 079 4.22% | 1 134 1 186 -4.41% | 1 660 1 394 19.06% | 1 005 1 049 -4.18% | 1 136 | 1 219 | 1 359 | ||
|
EBIT Million USD | Released Forecast Spread | 1 013 976 3.84% | 1 019 1 012 0.67% | 977 1 048 -6.8% | 1 130 1 165 -3.02% | 785 984 -20.19% | 1 011 956 5.8% | 1 020 1 063 -4.04% | 1 546 1 251 23.56% | 892 920 -3.09% | 1 032 | 1 115 | 1 214 | 949 | 1 091 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -971 403 -340.94% | -1 160 393 -395.17% | -1 100 430 -355.81% | 75,0 443 -83.07% | 507 180 181.67% | -467 141 -431.21% | 107 | 127 | 133 | |||||
|
Net income Million USD | Released Forecast Spread | -955 335 -384.9% | -232 236 -198.45% | 56,0 96,7 -42.1% | -1 221 584 -309.12% | -205 58,2 -452.48% | -863 -12,2 -6951.9% | 80,0 -192 141.73% | 461 1 055 -56.3% | -139 32,0 -534.38% | 39,0 | 56,5 | -15,8 | ||
|
EPS USD | Released Forecast Spread | -0,86 0,28 -404.92% | -0,21 0,06 -475.6% | 0,05 0,09 -42.12% | -1,10 0,50 -319.89% | -0,18 0,05 -447.89% | -0,77 -0,01 -7023.03% | 0,07 -0,35 119.73% | 0,41 0,53 -21.99% | -0,12 -0,05 -148.76% | -0,40 | 0,00 | 0,90 | ||
| Announcement Date | 03/05/22 | 26/07/22 | 03/11/22 | 08/02/23 | 10/05/23 | 02/08/23 | 08/11/23 | 31/01/24 | 08/05/24 | - | - | - | - | - |
More events
Past sector events for Teva Pharmaceutical Industries Limited
| 30/05/2024 13:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 30/05/2024 12:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 30/05/2024 07:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 13:00 | FDC LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 10:26 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 09:44 | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 09:10 | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 28/05/2024 | PFIZER LIMITED: Q4 2024 Earnings Release |
| 27/05/2024 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
| 27/05/2024 13:10 | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |